Figdor CG - Search Results

1

Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.

Schluck M, Hammink R, Figdor CG, Verdoes M, Weiden J. Schluck M, et al. Among authors: figdor cg. Front Immunol. 2019 May 3;10:931. doi: 10.3389/fimmu.2019.00931. eCollection 2019. Front Immunol. 2019. PMID: 31130945 Free PMC article. Review.

2

Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.

Schreurs MW, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: figdor cg. Cancer Res. 1998 Jun 15;58(12):2509-14. Cancer Res. 1998. PMID: 9635569

3

Generation and functional characterization of mouse monocyte-derived dendritic cells.

Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: figdor cg. Eur J Immunol. 1999 Sep;29(9):2835-41. doi: 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q. Eur J Immunol. 1999. PMID: 10508258 Free article.

4

Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.

Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: figdor cg. Crit Rev Oncog. 2000;11(1):1-17. Crit Rev Oncog. 2000. PMID: 10795625 Review.

5

In situ tumor ablation creates an antigen source for the generation of antitumor immunity.

den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ, Adema GJ. den Brok MH, et al. Among authors: figdor cg. Cancer Res. 2004 Jun 1;64(11):4024-9. doi: 10.1158/0008-5472.CAN-03-3949. Cancer Res. 2004. PMID: 15173017

6

Migration of dendritic cell based cancer vaccines: in vivo veritas?

Adema GJ, de Vries IJ, Punt CJ, Figdor CG. Adema GJ, et al. Among authors: figdor cg. Curr Opin Immunol. 2005 Apr;17(2):170-4. doi: 10.1016/j.coi.2005.01.004. Curr Opin Immunol. 2005. PMID: 15766677 Review.

7

Dendritic cells: tools and targets for antitumor vaccination.

den Brok MH, Nierkens S, Figdor CG, Ruers TJ, Adema GJ. den Brok MH, et al. Among authors: figdor cg. Expert Rev Vaccines. 2005 Oct;4(5):699-710. doi: 10.1586/14760584.4.5.699. Expert Rev Vaccines. 2005. PMID: 16221071 Review.

8

In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.

De Vries IJ, Bernsen MR, van Geloof WL, Scharenborg NM, Lesterhuis WJ, Rombout PD, Van Muijen GN, Figdor CG, Punt CJ, Ruiter DJ, Adema GJ. De Vries IJ, et al. Among authors: figdor cg. Cancer Immunol Immunother. 2007 Oct;56(10):1667-76. doi: 10.1007/s00262-007-0304-5. Epub 2007 Apr 18. Cancer Immunol Immunother. 2007. PMID: 17440724 Free PMC article.

9

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Tacken PJ, et al. Among authors: figdor cg. Nat Rev Immunol. 2007 Oct;7(10):790-802. doi: 10.1038/nri2173. Nat Rev Immunol. 2007. PMID: 17853902 Review.

10

Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients.

Jacobs JF, Aarntzen EH, Sibelt LA, Blokx WA, Boullart AC, Gerritsen MJ, Hoogerbrugge PM, Figdor CG, Adema GJ, Punt CJ, de Vries IJ. Jacobs JF, et al. Among authors: figdor cg. Cancer Immunol Immunother. 2009 Jan;58(1):145-51. doi: 10.1007/s00262-008-0506-5. Epub 2008 Apr 5. Cancer Immunol Immunother. 2009. PMID: 18392619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page